Company

Bristol-Myers Squibb Co BMY

Tracked across 6 disclosed holders on Protégé.

3 tracked investors, latest 13F quarter ending 30 Jun 2026 · 2 members of Congress · 1 executive · latest filing 14 Aug 2026

Held by these investors

All of 3 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Bill Miller0.9%$4.0M2026-06-302026-08-14
Cliff Asness0.5%$1.6B2026-06-302026-08-14
Two Sigma Investments0.5%$581.1M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Mike Kelly0 buys / 1 sell-$33K2026-05-07
Julie Johnson0 buys / 1 sell-$8K2025-12-18

Company executives who disclosed trades

Executives' own trades in this company's stock. Source: SEC Form 4; latest trade date per row.
ExecutiveDisclosed activityNetLatest trade
Christopher Boerner1 buy / 0 sells$110K2025-02-20

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for BMY